{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:21:42Z","timestamp":1787775702634,"version":"build-2784847793"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024786","name":"Instituto Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.biopha.2024.116742","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T16:24:11Z","timestamp":1715790251000},"page":"116742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection"],"prefix":"10.1016","volume":"175","author":[{"given":"Juliana Magalh\u00e3es Chaves","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Pedra-Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00edlton Ant\u00f4nio","family":"Mata-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glaucia","family":"Vilar-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Galv\u00e3o de","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isalira Peroba","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9882-0810","authenticated-orcid":false,"given":"Daniel","family":"Gibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otacilio C.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Ferreira","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Meuser","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-6754","authenticated-orcid":false,"given":"Joseli","family":"Lannes-Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Daliry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5397-718X","authenticated-orcid":false,"given":"Kelly","family":"Salom\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116742_bib1","unstructured":"PAHO. (2023). Organization Panamericana de la Salud-OPS. Enfermedad de Chagas en las Am\u00e9ricas: An\u00e1lisis de la Situaci\u00f3n Actual y Revisi\u00f3n Estrat\u00e9gica de la Agenda Regional. Available at: \u3008https:\/\/www.paho.org\/es\/documentos\/enfermedad-chagasamericas-analisis-situacion-actual-revision-estrategica-agenda\u3009. (Accessed January 14, 2024)."},{"issue":"10115","key":"10.1016\/j.biopha.2024.116742_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.biopha.2024.116742_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fpubh.2019.00166","article-title":"Chagas Disease: From Discovery to a Worldwide Health Problem","volume":"7","author":"Lidani","year":"2019","journal-title":"Front. Public Health"},{"issue":"12","key":"10.1016\/j.biopha.2024.116742_bib4","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1161\/CIR.0000000000000599","article-title":"Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association","volume":"138","author":"Nunes","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biopha.2024.116742_bib5","article-title":"SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023. Diretriz da SBC sobre Diagn\u00f3stico e Tratamento de Pacientes com Cardiomiopatia da Doen\u00e7a de Chagas \u2013 2023","volume":"120","author":"Marin-Neto","year":"2023","journal-title":"Arq. Bras. De. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.116742_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/0037-8682-0505-2016","article-title":"2 nd Brazilian Consensus on Chagas Disease, 2015","volume":"49","author":"Dias","year":"2016","journal-title":"Rev. da Soc. Bras. De. Med. Trop."},{"key":"10.1016\/j.biopha.2024.116742_bib7","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMct1014204","article-title":"Antitrypanosomal therapy for chronic Chagas' disease","author":"Bern","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2024.116742_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1590\/0074-02760160334","article-title":"Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial","volume":"112","author":"Rassi","year":"2017","journal-title":"Mem. do Inst. Oswaldo Cruz"},{"issue":"10","key":"10.1016\/j.biopha.2024.116742_bib9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.biopha.2024.116742_bib10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1590\/0074-0276130122","article-title":"A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention","volume":"108","author":"Machado-de-Assis","year":"2013","journal-title":"Mem. do Inst. Oswaldo Cruz"},{"issue":"14","key":"10.1016\/j.biopha.2024.116742_bib11","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2024.116742_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpddr.2019.11.004","article-title":"Current trends in the pharmacological management of Chagas disease","volume":"12","author":"Ribeiro","year":"2020","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.biopha.2024.116742_bib13","series-title":"Chagas Disease","article-title":"Etiologic Treatment of Chagas Disease: Old Drugs, New Insights, Challenges, and Perspectives","author":"Urbina","year":"2020"},{"issue":"8","key":"10.1016\/j.biopha.2024.116742_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2024.116742_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/JEP.S267378","article-title":"Review on Experimental Treatment Strategies Against Trypanosoma cruzi","volume":"13","author":"Mazzeti","year":"2021","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116742_bib16","article-title":"Prognosis of chronic Chagas heart disease and other pending clinical challenges","volume":"117","author":"Torres","year":"2022","journal-title":"Mem. do Inst. Oswaldo Cruz"},{"key":"10.1016\/j.biopha.2024.116742_bib17","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no SUS (2018). Protocolo cl\u0131nico e diretrizes terape \u0301 \u0302uticas: doen\u00e7a de chagas (Bras\u0131lia: \u0301Minist\u00e9rio da Sa\u00fade). Available at: \u3008http:\/\/conitec.gov.br\/images\/Consultas\/Relatorios\/2018\/Relatorio_PCDT_DoencaChagas_CP42_2018.pdf\u3009."},{"issue":"3","key":"10.1016\/j.biopha.2024.116742_bib18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/jm050691f","article-title":"Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole","volume":"49","author":"Benaim","year":"2006","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2024.116742_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrcardio.2012.108","article-title":"The emerging role of amiodarone and dronedarone in Chagas disease","volume":"9","author":"Benaim","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2024.116742_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.975931","article-title":"Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells","volume":"12","author":"Barbosa","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01852-21","article-title":"Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection","volume":"10","author":"Barbosa","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"4","key":"10.1016\/j.biopha.2024.116742_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002645","article-title":"CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi elicited cardiomyopathy","volume":"8","author":"Silverio","year":"2012","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.biopha.2024.116742_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005947","article-title":"Resveratrol Reverses Functional Chagas Heart Disease in Mice","volume":"12","author":"Vilar-Pereira","year":"2016","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.biopha.2024.116742_bib24","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1128\/AAC.02123-15","article-title":"Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease","volume":"60","author":"Vilar-Pereira","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.biopha.2024.116742_bib25","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(20)30844-6","article-title":"New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial","volume":"21","author":"Torrico","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2024.116742_bib26","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2147\/JPR.S196480","article-title":"Analgesic effects of amiodarone in mouse models of pain","volume":"12","author":"Kotoda","year":"2019","journal-title":"J. Pain. Res."},{"key":"10.1016\/j.biopha.2024.116742_bib27","first-page":"389","article-title":"Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi","volume":"4","author":"Brener","year":"1962","journal-title":"Rev. do Inst. De. Med. Trop. De. Sao Paulo"},{"issue":"5","key":"10.1016\/j.biopha.2024.116742_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jmoldx.2015.04.010","article-title":"Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients","volume":"17","author":"Ram\u00edrez","year":"2015","journal-title":"J. Mol. Diagn.: JMD"},{"issue":"3","key":"10.1016\/j.biopha.2024.116742_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003659","article-title":"Pentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell response","volume":"9","author":"Pereira","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"13","key":"10.1016\/j.biopha.2024.116742_bib30","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1017\/S0031182014001097","article-title":"Levels of circulating anti-muscarinic and anti-adrenergic antibodies and their effect on cardiac arrhythmias and dysautonomia in murine models of Chagas disease","volume":"141","author":"Daliry","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2024.116742_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.712034","article-title":"Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease","volume":"12","author":"Pedra-Rezende","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116742_bib32","series-title":"Cellular and Molecular Immunology","author":"Abbas","year":"2018"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.116742_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S0074-02762009000900021","article-title":"Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification","volume":"104","author":"Rassi","year":"2009","journal-title":"Mem. do Inst. Oswaldo Cruz"},{"issue":"7","key":"10.1016\/j.biopha.2024.116742_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007602","article-title":"TGF-\u03b2 inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease","volume":"13","author":"Ferreira","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2024.116742_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/019131290923974","article-title":"Myocardiocyte ultrastructure and morphometrical analysis in hamsters experimentally infected with Trypanosoma cruzi","volume":"29","author":"Colmanetti","year":"2005","journal-title":"Ultrastruct. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.micinf.2007.09.017","article-title":"Trypanosoma cruzi induces changes in cardiac connexin 43 expression","volume":"10","author":"Adesse","year":"2008","journal-title":"Microbes Infect."},{"issue":"8","key":"10.1016\/j.biopha.2024.116742_bib37","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1590\/S0074-02762009000800004","article-title":"Gap junction reduction in cardiomyocytes following transforming growth factor-beta treatment and Trypanosoma cruzi infection","volume":"104","author":"Waghabi","year":"2009","journal-title":"Mem. do Inst. Oswaldo Cruz"},{"key":"10.1016\/j.biopha.2024.116742_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fimmu.2012.00327","article-title":"Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction","volume":"3","author":"Calvet","year":"2012","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/AAC.01129-10","article-title":"Amiodarone inhibits Trypanosoma cruzi infection and promotes cardiac cell recovery with gap junction and cytoskeleton reassembly in vitro","volume":"55","author":"Adesse","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.116742_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fphys.2014.00309","article-title":"Hypertrophic cardiomyopathy: a heart in need of an energy bar?","volume":"5","author":"Vakrou","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2024.116742_bib41","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-012-0351-7","article-title":"Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease","author":"Machado","year":"2012","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13000-021-01100-8","article-title":"Danon disease: a case report and literature review","volume":"16","author":"Xu","year":"2021","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.biopha.2024.116742_bib43","article-title":"Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach. Memorias","volume":"117","author":"Lannes-Vieira","year":"2022","journal-title":"do Inst. Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.biopha.2024.116742_bib44","first-page":"171","article-title":"Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease","volume":"12","author":"Koh","year":"2023","journal-title":"Pathog. (Basel, Switz. )"},{"issue":"5-6","key":"10.1016\/j.biopha.2024.116742_bib45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0020-7519(01)00171-0","article-title":"Parasite polyclonal activators: new targets for vaccination approaches?","volume":"31","author":"Minoprio","year":"2001","journal-title":"Int. J. Parasitol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116742_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/0074-0276140033","article-title":"Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease","volume":"109","author":"Pereira","year":"2014","journal-title":"Mem. do Inst. Oswaldo Cruz"},{"issue":"8","key":"10.1016\/j.biopha.2024.116742_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006742","article-title":"Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis","volume":"12","author":"Stein","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2024.116742_bib48","first-page":"367","article-title":"Terap\u00eautica emp\u00edrica com amiodarona em portadores de miocardiopatia chag\u00e1sica cr\u00f4nica e taquicardia ventricular sustentada [Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia]","volume":"54","author":"Scanavacca","year":"1990","journal-title":"Arq. Bras. De. Cardiol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116742_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2007.02.045","article-title":"Acute toxic hepatitis after amiodarone intravenous loading","volume":"25","author":"Rizzioli","year":"2007","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.biopha.2024.116742_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104521","article-title":"The role of amiodarone in contemporary management of complex cardiac arrhythmias","volume":"151","author":"Mujovi\u0107","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.biopha.2024.116742_bib51","first-page":"2192","article-title":"Multiple-dose kinetics of the trypanosomicide benznidazole in man","volume":"30","author":"Raaflaub","year":"1980","journal-title":"Arzneim. -Forsch."},{"issue":"2","key":"10.1016\/j.biopha.2024.116742_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","article-title":"Clinical pharmacokinetics of amiodarone","volume":"9","author":"Latini","year":"1984","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.biopha.2024.116742_bib53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10928-018-9576-y","article-title":"A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data","volume":"45","author":"Dallefeld","year":"2018","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"5","key":"10.1016\/j.biopha.2024.116742_bib54","first-page":"329","article-title":"Avalia\u00e7\u00e3o da fun\u00e7\u00e3o e da les\u00e3o renal: um desafio laboratorial","volume":"43","author":"Sodr\u00e9","year":"2007","journal-title":"J. Bras. De. Patol. e Med. Lab."},{"issue":"5","key":"10.1016\/j.biopha.2024.116742_bib55","article-title":"Acute Fulminant Hepatic Failure and Renal Failure Induced by Oral Amiodarone: A Case Report and Literature Review","volume":"12","author":"Campbell","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.biopha.2024.116742_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003464","article-title":"Trypanosoma cruzi infection is a potent risk factor for non alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders","volume":"9","author":"Onofrio","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2024.116742_bib57","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0006-2952(84)90511-2","article-title":"Reductive metabolism and activation of benznidazole","volume":"33","author":"Masana","year":"1984","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116742_bib58","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2165\/00003088-200746120-00002","article-title":"Antiarrhythmics: elimination and dosage considerations in hepatic impairment","volume":"46","author":"Klotz","year":"2007","journal-title":"Clin. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.biopha.2024.116742_bib59","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00436-015-4488-x","article-title":"Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice","volume":"114","author":"Novaes","year":"2015","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jat.3141","article-title":"Establishment of a mouse model for amiodarone-induced liver injury and analyses of its hepatotoxic mechanism","volume":"36","author":"Takai","year":"2016","journal-title":"J. Appl. Toxicol.: JAT"},{"issue":"2","key":"10.1016\/j.biopha.2024.116742_bib61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2362.1983.tb00076.x","article-title":"Determination of cardiac and plasma drug levels during long-term amiodarone therapy","volume":"13","author":"Debbas","year":"1983","journal-title":"Eur. J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.biopha.2024.116742_sbref60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2460\/javma.255.3.317","article-title":"Investigation of a combination of amiodarone and itraconazole for treatment of American trypanosomiasis (Chagas disease) in dogs","volume":"255","author":"Madigan","year":"2019","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.biopha.2024.116742_sbref61","article-title":"Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach","volume":"117","author":"Lannes-Vieira","year":"2022","journal-title":"Mem. do Inst. Oswaldo Cruz"},{"issue":"9","key":"10.1016\/j.biopha.2024.116742_sbref62","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMct065916","article-title":"Amiodarone for atrial fibrillation","volume":"356","author":"Zimetbaum","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.biopha.2024.116742_sbref63","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.biopha.2024.116742_bib64","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1086\/648072","article-title":"Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy","volume":"49","author":"Laucella","year":"2009","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.biopha.2024.116742_bib65","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3389\/fimmu.2018.01958","article-title":"Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes","volume":"9","author":"Albareda","year":"2018","journal-title":"Front. 133 Immunol."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116742_bib66","first-page":"84","article-title":"Immunoneuroendocrine alterations in patients with progressive forms of neuroimmunology","volume":"235","author":"P\u00e9rez","year":"2011","journal-title":"Chronic Chagas"},{"issue":"3","key":"10.1016\/j.biopha.2024.116742_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087082","article-title":"Plasma cytokine expression is associated with cardiac morbidity in chagas disease","volume":"9","author":"Sousa","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12879-017-2324-x","article-title":"Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status","volume":"17","author":"Rodr\u00edguez-Angulo","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib69","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4049\/jimmunol.173.1.463","article-title":"Intercellular adhesion molecule 1 deficiency leads to impaired recruitment of T lymphocytes and enhanced host susceptibility to infection with Trypanosoma cruzi","volume":"173","author":"Michailowsky","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116742_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003770","article-title":"Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin","volume":"9","author":"Campos-Estrada","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2024.116742_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.692655","article-title":"Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy","volume":"11","author":"Farani","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"5-6","key":"10.1016\/j.biopha.2024.116742_bib72","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0020-7519(01)00171-0","article-title":"Parasite polyclonal activators: new targets for vaccination approaches?","volume":"31","author":"Minoprio","year":"2001","journal-title":"Int. J. Parasitol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116742_bib73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S0074-02762003000300021","article-title":"Increased plasma levels of tumor necrosis factor-alpha in asymptomatic\/\"indeterminate\" and patients","volume":"98","author":"Ferreira","year":"2003","journal-title":"Mem. do Inst. Chagas Oswaldo Dis. cardiomyopathy Cruz"},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12879-017-2324-x","article-title":"Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status","volume":"17","author":"Rodr\u00edguez-Angulo","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.biopha.2024.116742_bib75","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fimmu.2020.00306","article-title":"CCL3\/Macrophage Inflammatory Protein-1\u03b1 Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFN\u03b3-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy","volume":"11","author":"Gibaldi","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10741-010-9180-8","article-title":"TNF\u03b1 in myocardial ischemia\/reperfusion, remodeling and heart failure","volume":"16","author":"Kleinbongard","year":"2011","journal-title":"Heart Fail. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116742_bib77","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/01.CIR.96.5.1386","article-title":"Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: a possible mechanism for its effect in heart failure","volume":"96","author":"Matsumori","year":"1997","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biopha.2024.116742_bib78","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1253\/circj.CJ-08-0794","article-title":"Short term amiodarone treatment attenuates the production of monocyte cytokines and chemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventricular tachycardia","volume":"73","author":"Hirasawa","year":"2009","journal-title":"Circ. J.: Off. J. Jpn. Circ. Soc."},{"issue":"3","key":"10.1016\/j.biopha.2024.116742_bib79","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0020-7519(02)00283-7","article-title":"Severity of chronic Chagas disease is associated with cytokine\/antioxidant imbalance in chronically infected individuals","volume":"33","author":"P\u00e9rez-Fuentes","year":"2003","journal-title":"Int. J. Parasitol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116742_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006687","article-title":"Manganese superoxide dismutase deficiency exacerbates the mitochondrial ROS production and oxidative damage in Chagas disease","volume":"12","author":"Wen","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2024.116742_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.755862","article-title":"Co-Exposure of Cardiomyocytes to IFN-\u03b3 and TNF-\u03b1 Induces Mitochondrial Dysfunction and Nitro-Oxidative Stress: Implications for the Pathogenesis of Chronic Chagas Disease Cardiomyopathy","volume":"12","author":"Nunes","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116742_bib82","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1286-4579(02)01609-X","article-title":"Macrophage signaling by glycosylphosphatidylinositol-anchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes","volume":"4","author":"Ropert","year":"2002","journal-title":"Microbes Infect."},{"issue":"6-7","key":"10.1016\/j.biopha.2024.116742_bib83","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.molimm.2010.12.021","article-title":"Benznidazole treatment attenuates liver NF-\u03baB activity and MAPK in a cecal ligation and puncture model of sepsis","volume":"48","author":"Ronco","year":"2011","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1535370214544263","article-title":"Modulation of both activator protein-1 and nuclear factor kappa B signal transduction of human T cells by amiodarone","volume":"240","author":"Cheng","year":"2015","journal-title":"Exp. Biol. Med. (Maywood, N. J. )"},{"key":"10.1016\/j.biopha.2024.116742_bib85","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.taap.2016.11.015","article-title":"Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis","volume":"315","author":"Lambertucci","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"15","key":"10.1016\/j.biopha.2024.116742_bib86","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.molimm.2010.06.002","article-title":"Benznidazole blocks NF-kappaB activation but not AP-1 through inhibition of IKK.","volume":"47","author":"Manarin","year":"2010","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116742_bib87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpddr.2015.12.001","article-title":"Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain","volume":"6","author":"Cevey","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"2","key":"10.1016\/j.biopha.2024.116742_bib88","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/path.4187","article-title":"Tumour necrosis factor in infectious disease","volume":"230","author":"Waters","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2024.116742_bib89","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/798078","article-title":"Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease","volume":"2014","author":"Pereira","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2024.116742_bib90","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4419-6612-4_23","article-title":"TNF-\u03b1 and TNFR in Chagas disease: from protective immunity to pathogenesis of chronic cardiomyopathy","volume":"691","author":"Lannes-Vieira","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116742_bib91","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1054-8807(01)00078-3","article-title":"The role of myocardial gap junctions in electrical conduction and arrhythmogenesis","volume":"10","author":"Kanno","year":"2001","journal-title":"Cardiovasc. Pathol.: Off. J. Soc. Cardiovasc. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116742_bib92","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ccep.2015.03.016","article-title":"Arrhythmias in chagasic cardiomyopathy","volume":"7","author":"Healy","year":"2015","journal-title":"Card. Electrophysiol. Clin."},{"issue":"4","key":"10.1016\/j.biopha.2024.116742_bib93","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1253\/circj.CJ-09-0038","article-title":"Does anti-inflammatory action of amiodarone explain the high efficacy in patients with heart failure?","volume":"73","author":"Nakaya","year":"2009","journal-title":"Circ. J.: Off. J. Jpn. Circ. Soc."},{"issue":"7","key":"10.1016\/j.biopha.2024.116742_bib94","first-page":"552","article-title":"Adverse reactions of Amiodarone","volume":"16","author":"Colunga Biancatelli","year":"2019","journal-title":"JGC"},{"issue":"7","key":"10.1016\/j.biopha.2024.116742_bib95","first-page":"552","article-title":"Adverse reactions of Amiodarone","volume":"16","author":"Colunga Biancatelli","year":"2019","journal-title":"JGC"},{"key":"10.1016\/j.biopha.2024.116742_bib96","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-308X(08)60472-8","article-title":"Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis","volume":"6","author":"K\u00f6berle","year":"1968","journal-title":"Adv. Parasitol."},{"issue":"9-10","key":"10.1016\/j.biopha.2024.116742_bib97","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/j.micinf.2006.06.006","article-title":"Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease","volume":"8","author":"Talvani","year":"2006","journal-title":"Microbes Infect."},{"issue":"4","key":"10.1016\/j.biopha.2024.116742_bib98","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1253\/circj.CJ-08-0794","article-title":"Short term amiodarone treatment attenuates the production of monocyte cytokines and chemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventricular tachycardia","volume":"73","author":"Hirasawa","year":"2009","journal-title":"Circ. J.: Off. J. Jpn. Circ. Soc."},{"issue":"5","key":"10.1016\/j.biopha.2024.116742_bib99","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/01.CIR.96.5.1386","article-title":"Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: a possible mechanism for its effect in heart failure","volume":"96","author":"Matsumori","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116742_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104521","article-title":"The role of amiodarone in contemporary management of complex cardiac arrhythmias","volume":"151","author":"Mujovi\u0107","year":"2020","journal-title":"Pharmacol. Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T14:42:36Z","timestamp":1741012956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224006267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":102,"alternative-id":["S0753332224006267"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116742","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116742"}}